Literature DB >> 23426503

Comparative effectiveness of minimally invasive and open distal pancreatectomy for ductal adenocarcinoma.

Deepa Magge1, William Gooding, Haroon Choudry, Jennifer Steve, Jennifer Steel, Amer Zureikat, Alyssa Krasinskas, Mustapha Daouadi, Kenneth K W Lee, Steven J Hughes, Herbert J Zeh, A James Moser.   

Abstract

IMPORTANCE: Multicenter studies indicate that outcomes of open (ODP) and minimally invasive distal pancreatectomy (MIDP) are equivalent for benign lesions. However, data for pancreatic carcinoma are limited.
OBJECTIVE: To compare outcomes of ODP and MIDP for early-stage pancreatic ductal carcinoma to determine relative safety and oncologic efficacy.
DESIGN: Retrospective analysis of 62 consecutive patients undergoing ODP or MIDP for pancreatic ductal carcinoma by intention to treat with propensity scoring to correct for selection bias.
SETTING: A high-volume university center for pancreatic surgery. PARTICIPANTS: Sixty-two patients at a single institution.
INTERVENTIONS: Patients underwent ODP or MIDP. MAIN OUTCOME MEASURES: Perioperative mortality, morbidity, readmission, postoperative complications, disease progression, and overall survival.
RESULTS: Thirty-four patients underwent ODP, and 28 underwent MIDP with 5 conversions to ODP. No significant differences in age, body mass index, performance status, tumor size, or radiographic stage were identified. High rates of margin-negative resection (ODP, 88%; MIDP, 86%) and median lymph node clearance (ODP, 12; MIDP, 11) were achieved in both groups with equal rates and severity of postoperative complications (ODP, 50%; MIDP, 39%) and pancreatic fistula (ODP, 29%; MIDP, 21%). Despite conversions, intended MIDP was associated with reduced blood loss (P = .006) and length of stay (P = .04). Conversion was associated with a poor histologic grade and positive nodes. Median overall survival for the entire cohort was 19 (95% CI, 14-47) months. Minimally invasive distal pancreatectomy was performed increasingly in later study years and for patients with a higher Charlson-Age Comorbidity Index. Overall survival after ODP or intended MIDP was equivalent after adjusting for comorbidity and year of surgery (relative hazard, 1.11 [95% CI, 0.47-2.62]). CONCLUSIONS AND RELEVANCE: We detected no evidence that MIDP was inferior to ODP based on postoperative outcomes or overall survival. This conclusion was verified by propensity score analysis with adjustment for factors affecting selection of operative technique.

Entities:  

Mesh:

Year:  2013        PMID: 23426503     DOI: 10.1001/jamasurg.2013.1673

Source DB:  PubMed          Journal:  JAMA Surg        ISSN: 2168-6254            Impact factor:   14.766


  49 in total

1.  Laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma: results of a multicenter cohort study on 196 patients.

Authors:  Mushegh A Sahakyan; Airazat M Kazaryan; Majd Rawashdeh; David Fuks; Mark Shmavonyan; Sven-Petter Haugvik; Knut Jørgen Labori; Trond Buanes; Bård Ingvald Røsok; Dejan Ignjatovic; Mohammad Abu Hilal; Brice Gayet; Song Cheol Kim; Bjørn Edwin
Journal:  Surg Endosc       Date:  2015-10-30       Impact factor: 4.584

Review 2.  Laparoscopic and robot-assisted laparoscopic digestive surgery: Present and future directions.

Authors:  Juan C Rodríguez-Sanjuán; Marcos Gómez-Ruiz; Soledad Trugeda-Carrera; Carlos Manuel-Palazuelos; Antonio López-Useros; Manuel Gómez-Fleitas
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

Review 3.  Laparoscopic pancreatic surgery for benign and malignant disease.

Authors:  Thijs de Rooij; Sjors Klompmaker; Mohammad Abu Hilal; Michael L Kendrick; Olivier R Busch; Marc G Besselink
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-17       Impact factor: 46.802

Review 4.  Laparoscopic distal pancreatosplenectomy for pancreatic ductal adenocarcinoma.

Authors:  Tamotsu Kuroki; Susumu Eguchi
Journal:  Surg Today       Date:  2014-08-26       Impact factor: 2.549

5.  Improved perioperative outcomes with minimally invasive distal pancreatectomy: results from a population-based analysis.

Authors:  Hop S Tran Cao; Nicole Lopez; David C Chang; Andrew M Lowy; Michael Bouvet; Joel M Baumgartner; Mark A Talamini; Jason K Sicklick
Journal:  JAMA Surg       Date:  2014-03       Impact factor: 14.766

6.  The learning curve for robotic distal pancreatectomy: an analysis of outcomes of the first 100 consecutive cases at a high-volume pancreatic centre.

Authors:  Murtaza Shakir; Brian A Boone; Patricio M Polanco; Mazen S Zenati; Melissa E Hogg; Allan Tsung; Haroon A Choudry; A James Moser; David L Bartlett; Herbert J Zeh; Amer H Zureikat
Journal:  HPB (Oxford)       Date:  2015-04-23       Impact factor: 3.647

Review 7.  Laparoscopic versus open distal pancreatectomy for ductal adenocarcinoma: a systematic review and meta-analysis.

Authors:  Claudio Ricci; Riccardo Casadei; Giovanni Taffurelli; Fabrizio Toscano; Carlo Alberto Pacilio; Selene Bogoni; Marielda D'Ambra; Nico Pagano; Maria Cristina Di Marco; Francesco Minni
Journal:  J Gastrointest Surg       Date:  2015-01-06       Impact factor: 3.452

8.  Short-term and long-term outcomes after robot-assisted versus laparoscopic distal pancreatectomy for pancreatic neuroendocrine tumors (pNETs): a multicenter comparative study.

Authors:  Sergio Alfieri; Giovanni Butturini; Ugo Boggi; Andrea Pietrabissa; Luca Morelli; Fabio Vistoli; Isacco Damoli; Andrea Peri; Claudio Fiorillo; Luigi Pugliese; Marco Ramera; Nelide De Lio; Gregorio Di Franco; Alessandro Esposito; Luca Landoni; Fausto Rosa; Roberta Menghi; Giovanni Battista Doglietto; Giuseppe Quero
Journal:  Langenbecks Arch Surg       Date:  2019-05-04       Impact factor: 3.445

9.  Laparoscopic spleen-preserving distal pancreatectomy: the technique must suit the lesion.

Authors:  David J Worhunsky; Yulia Zak; Monica M Dua; George A Poultsides; Jeffrey A Norton; Brendan C Visser
Journal:  J Gastrointest Surg       Date:  2014-06-18       Impact factor: 3.452

10.  Minimally Invasive Distal Pancreatectomy for Cancer: Short-Term Oncologic Outcomes in 1,733 Patients.

Authors:  Mohamed Abdelgadir Adam; Kingshuk Choudhury; Paolo Goffredo; Shelby D Reed; Dan Blazer; Sanziana A Roman; Julie A Sosa
Journal:  World J Surg       Date:  2015-10       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.